Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92,448,158
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
9,017,971
-
Shares change
-
+202,136
-
Total reported value, excl. options
-
$104,753,394
-
Value change
-
+$2,578,213
-
Number of buys
-
23
-
Number of sells
-
-8
-
Price
-
$11.62
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q2 2019
43 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q2 2019.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,017,971 shares
of 92,448,158 outstanding shares and own 9.8% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3,410,412 shares), ORBIMED ADVISORS LLC (1,479,733 shares), Fosun International Ltd (794,279 shares), BlackRock Inc. (634,441 shares), FMR LLC (621,800 shares), KORNITZER CAPITAL MANAGEMENT INC /KS (482,898 shares), VANGUARD GROUP INC (457,103 shares), STATE STREET CORP (181,328 shares), Point72 Asset Management, L.P. (142,206 shares), and Asymmetry Capital Management, L.P. (132,820 shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.